| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 134, 1602-1610, Copyright © 1994 by Endocrine Society
ARTICLES |
S Lee, SA Clark, RK Gill and S Christakos
Department of Biochemistry, University of Massachusetts Medical Center, Worcester 01605.
Previous studies have indicated that the pancreas has receptors specific for 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] and that 1,25- (OH)2D3 increases insulin secretion in vitamin D-deficient rats. In this study we report that in vitamin D-replete, but calcium-deficient, rats in which 1,25-(OH)2D3 levels are elevated, insulin secretion is not altered. In addition, in in vitro studies 1,25-(OH)2D3 at concentrations of 10(-10)-10(-7) M was consistently found to inhibit insulin secretion from islets of vitamin D-replete rats or from the rat insulinoma beta-cell line RIN 1046-38. The RIN cell line was found to contain both vitamin D receptors and calbindin-D28k (CaBP-D28k) protein and mRNA. In RIN cells, treatment with sodium butyrate (2 mM for 3 days) induces a more islet phenotype, as indicated by increased insulin content and secretion and increased insulin gene expression. 1,25- (OH)2D3 treatment (50-100 nM for 48 or 72 h) had no effect on the enhanced levels of insulin secreted in the presence of butyrate. However, 2 mM sodium butyrate induced CaBP-D28k protein (4-fold; control, 0.8 +/- 0.2; sodium butyrate, 3.5 +/- 0.1 microgram/mg protein) and mRNA (3-fold) in the RIN cell line, in accord with the induction by butyrate of insulin content and secretion and beta-cell differentiation, suggesting a possible role for CaBP-D28k in these processes. Although 1,25-(OH)2D3, unlike butyrate, did not enhance insulin secretion, both 1,25-(OH)2D3 (100 nM) and butyrate (2 mM) inhibited RIN cell growth (to 69% and 28% of the control, respectively), and butyrate and 1,25-(OH)2D3 in combination led to a further inhibition of cell growth (to 13% of the control). In response to 1,25-(OH)2D3 (10 nM for 72 h), vitamin D receptors were up-regulated 313% in RIN cells [control, 37 +/- 2; 1,25-(OH)2D3 treated, 115 +/- 5 fmol/mg protein]. In conclusion, 1) contrary to previous studies in the vitamin D-deficient rat, our findings indicate that 1,25-(OH)2D3 action does not necessarily result in enhanced insulin secretion; 2) inhibition of cell growth and up-regulation of vitamin D receptors by 1,25-(OH)2D3 suggest that parameters in addition to insulin secretion can be affected by 1,25-(OH)2D3 in the beta-cell; 3) the RIN beta-cell line provides a novel in vitro system for studying the effect of the vitamin D endocrine system on pancreatic islet physiology.
This article has been cited by other articles:
![]() |
J. P. Reis, D. von Muhlen, D. Kritz-Silverstein, D. L. Wingard, and E. Barrett-Connor Vitamin D, Parathyroid Hormone Levels, and the Prevalence of Metabolic Syndrome in Community-Dwelling Older Adults Diabetes Care, June 1, 2007; 30(6): 1549 - 1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B Snijder, A. A. van der Heijden, R. M van Dam, C. D. Stehouwer, G. J Hiddink, G. Nijpels, R. J Heine, L. M Bouter, and J. M Dekker Is higher dairy consumption associated with lower body weight and fewer metabolic disturbances? The Hoorn Study Am. J. Clinical Nutrition, April 1, 2007; 85(4): 989 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Schneider, C. El-Yazidi, A. Dace, M. Maraninchi, R. Planells, A. Margotat, and J. Torresani Expression of the 1,25-(OH)2 vitamin D3 receptor gene during the differentiation of mouse Ob17 preadipocytes and cross talk with the thyroid hormone receptor signalling pathway J. Mol. Endocrinol., February 1, 2005; 34(1): 221 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F Holick Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1678S - 1688S. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Bakken and C. D. Hunt Dietary Boron Decreases Peak Pancreatic In Situ Insulin Release in Chicks and Plasma Insulin Concentrations in Rats Regardless of Vitamin D or Magnesium Status J. Nutr., November 1, 2003; 133(11): 3577 - 3583. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Riachy, B. Vandewalle, J. Kerr Conte, E. Moerman, P. Sacchetti, B. Lukowiak, V. Gmyr, T. Bouckenooghe, M. Dubois, and F. Pattou 1,25-Dihydroxyvitamin D3 Protects RINm5F and Human Islet Cells against Cytokine-Induced Apoptosis: Implication of the Antiapoptotic Protein A20 Endocrinology, December 1, 2002; 143(12): 4809 - 4819. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Galbiati, L. Polastri, S. Gregori, M. Freschi, M. Casorati, U. Cavallaro, P. Fiorina, F. Bertuzzi, A. Zerbi, G. Pozza, et al. Antitumorigenic and Antiinsulinogenic Effects of Calcitriol on Insulinoma Cells and Solid {beta}-Cell Tumors Endocrinology, October 1, 2002; 143(10): 4018 - 4030. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W.J. Janssen, J. G.J. Hoenderop, A. R.M.M. Hermus, F. C.G.J. Sweep, G. J.M. Martens, and R. J.M. Bindels Expression of the Novel Epithelial Ca2+ Channel ECaC1 in Rat Pancreatic Islets J. Histochem. Cytochem., June 1, 2002; 50(6): 789 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sooy, T. Schermerhorn, M. Noda, M. Surana, W. B. Rhoten, M. Meyer, N. Fleischer, G. W. G. Sharp, and S. Christakos Calbindin-D28k Controls [Ca2+]i and Insulin Release. EVIDENCE OBTAINED FROM CALBINDIN-D28k KNOCKOUT MICE AND beta CELL LINES J. Biol. Chem., November 26, 1999; 274(48): 34343 - 34349. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kajikawa, H. Ishida, S. Fujimoto, E. Mukai, M. Nishimura, J. Fujita, Y. Tsuura, Y. Okamoto, A. W. Norman, and Y. Seino An Insulinotropic Effect of Vitamin D Analog with Increasing Intracellular Ca2+ Concentration in Pancreatic {beta}-Cells through Nongenomic Signal Transduction Endocrinology, October 1, 1999; 140(10): 4706 - 4712. [Abstract] [Full Text] |
||||
![]() |
M.-A. Huotari, J. Palgi, and T. Otonkoski Growth Factor-Mediated Proliferation and Differentiation of Insulin-Producing INS-1 and RINm5F Cells: Identification of Betacellulin as a Novel {beta}-Cell Mitogen Endocrinology, April 1, 1998; 139(4): 1494 - 1499. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Reddy, A. S. Pollock, S. A. Clark, K. Sooy, R. C. Vasavada, A. F. Stewart, T. Honeyman, and S. Christakos Transfection and overexpression of the calcium binding protein calbindin-D28k results in a stimulatory effect on insulin synthesis in a rat beta cell line (RIN 1046-38) PNAS, March 4, 1997; 94(5): 1961 - 1966. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |